{"id":"W4410085374","doi":"10.1016/j.euo.2025.04.012","title":"Niraparib and Abiraterone Acetate plus Prednisone in Metastatic Castration-resistant Prostate Cancer: Final Overall Survival Analysis for the Phase 3 MAGNITUDE Trial","year":2025,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Janssen Research and Development; Johnson and Johnson","keywords":"Abiraterone acetate; Medicine; Prednisone; Prostate cancer; Abiraterone; Oncology; Castration; Internal medicine; Urology; Cancer; Androgen deprivation therapy; Hormone; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001291369,0.000227555,0.0007504828,0.0003854348,0.0001905101,0.00003564339,0.0001549926,0.0000683866,0.00008113769],"category_scores_gemma":[0.0001532589,0.0001539443,0.0001323308,0.0004872512,0.0004282711,0.00005749562,0.00009814242,0.0003408307,0.00000621818],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002412279,"about_ca_system_score_gemma":0.0009140854,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003169866,"about_ca_topic_score_gemma":0.002235719,"domain_scores_codex":[0.9974335,0.0008436445,0.0005532144,0.0005101034,0.0001474024,0.0005121486],"domain_scores_gemma":[0.9986454,0.0006806363,0.0001578981,0.0002809167,0.0001337534,0.0001013684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8822148,0.003183578,0.02418881,0.0003811332,0.01070515,0.002402559,0.003425517,0.003240578,0.01044415,0.001309492,0.003019953,0.05548432],"study_design_scores_gemma":[0.6706325,0.02194694,0.2119693,0.00004103305,0.008480398,0.00004753922,0.0005433005,0.01022552,0.0003918755,0.0004785407,0.07481298,0.0004300701],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9746462,0.005152519,0.0006504553,0.01414953,0.0004238574,0.002980673,0.0001604639,0.00003690927,0.001799381],"genre_scores_gemma":[0.9912588,0.001541391,0.0003260224,0.0008872151,0.000119904,0.0005419053,0.0001667547,0.00002513748,0.005132844],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2115823,"threshold_uncertainty_score":0.6277665,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08226572202178561,"score_gpt":0.4067053165190906,"score_spread":0.324439594497305,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}